Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | N/A | 0 | 67,209 |
| Other current assets | 0 | 0 | 0 | 0 | 1,235 |
| TOTAL | $0 | $0 | $N/A | $0 | $68,444 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 4,334 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $4,334 |
| Total Assets | $0 | $0 | $N/A | $0 | $74,579 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 5,815 |
| Accrued Expenses | 0 | 0 | N/A | 0 | 19,437 |
| TOTAL | $0 | $0 | $N/A | $0 | $25,967 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 240,086 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $240,086 |
| Total Liabilities | $0 | $0 | $N/A | $0 | $266,865 |
| Shareholders' Equity | |||||
| Retained earnings | 0 | 0 | N/A | 0 | -193,279 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | -41 |
| TOTAL | $0 | $0 | $N/A | $0 | $-192,286 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $74,579 |